Drug Price Trends for NDC 69584-0426

Average Pharmacy Cost for 69584-0426

Drug Name	NDC	Price/Unit ($)	Unit	Date
IMIPRAMINE HCL 25 MG TABLET	69584-0426-90	0.09024	EACH	2025-04-23
IMIPRAMINE HCL 25 MG TABLET	69584-0426-10	0.09024	EACH	2025-04-23
IMIPRAMINE HCL 25 MG TABLET	69584-0426-90	0.09437	EACH	2025-03-19
IMIPRAMINE HCL 25 MG TABLET	69584-0426-10	0.09437	EACH	2025-03-19
IMIPRAMINE HCL 25 MG TABLET	69584-0426-90	0.09227	EACH	2025-02-19

Best Wholesale Price for NDC 69584-0426

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type
IMIPRAMINE HCL 25MG TAB	Nationwide Pharmaceutical LLC	69584-0426-90	1000	54.15	0.05415	2022-04-15 - 2026-04-30	FSS
IMIPRAMINE HCL 25MG TAB	Nationwide Pharmaceutical LLC	69584-0426-10	100	5.86	0.05860	2022-04-15 - 2026-04-30	FSS

Market Analysis and Price Projections for NDC 69584-0426

The pharmaceutical industry is constantly evolving, with drug prices and market dynamics playing a crucial role in shaping healthcare accessibility and affordability. In this comprehensive analysis, we'll delve into the market trends and price projections for the drug associated with NDC 69584-0426, exploring various factors that influence its pricing and market position.

Understanding the National Drug Code (NDC)

The National Drug Code (NDC) is a unique, three-segment number assigned by the Food and Drug Administration (FDA) to identify human drugs in the United States. It serves as a universal product identifier for drug products[1]. The NDC for our analysis, 69584-0426, provides specific information about the drug's manufacturer, product, and package size.

Current Market Status

Manufacturer and Product Details

While the specific details for NDC 69584-0426 are not provided in the search results, we can draw insights from similar drug products in the market. Pharmaceutical companies often have a portfolio of drugs that includes both brand-name and generic medications[3].

Pricing History and Trends

Generic drug prices can fluctuate significantly based on various factors. For instance, in 2022, the median price increase for generic drugs was 19.9%[3]. This trend suggests that even generic medications can experience substantial price changes over time.

"Generic drugs have historically seen both increases and decreases in prices. A notable example is a generic naproxen manufactured by Hikma Pharmaceuticals, which experienced a 2,527% price increase from 2012 to 2021."[3]

Factors Influencing Drug Pricing

Market Demand

The demand for a specific drug can significantly impact its pricing. Drugs treating common conditions or those with few alternatives often see stable or increasing demand, which can lead to price increases[3].

Production Costs

Changes in raw material prices, manufacturing overheads, and supply chain disruptions can all affect the production costs of pharmaceuticals. These factors can directly influence the pricing strategy for drugs like NDC 69584-0426[3].

Regulatory Environment

The pharmaceutical industry is heavily regulated, and changes in policies can have a substantial impact on drug pricing. For example, programs like Oregon's Drug Price Transparency Program require manufacturers to report price increases and new high-cost drugs, aiming to address the lack of transparency in the pharmaceutical supply chain[3].

Industry Trends Shaping the Market

Focus on Personalized Medicine

The pharmaceutical industry is increasingly moving towards personalized treatments, leveraging data-driven approaches to develop targeted therapies. This trend could influence the pricing and market position of drugs like NDC 69584-0426, especially if it falls within a therapeutic area amenable to personalization[3].

Emphasis on Prevention and Early Intervention

There's a growing focus on preventive care and early intervention in healthcare. Drugs that align with this trend may see increased demand and potentially higher prices, as they contribute to long-term health outcomes and potential cost savings in the healthcare system[3].

Price Projections for NDC 69584-0426

Short-term Outlook

Based on industry trends and historical data for similar drugs, we can project potential price movements for NDC 69584-0426 in the short term:

1. Moderate Increase Scenario: A price increase of 5-10% could be expected if market conditions remain stable and there are no significant changes in production costs or the regulatory environment[3].

2. Higher Increase Scenario: If there's a surge in demand or significant increases in production costs, the price could potentially rise by 15-20%[3].

Long-term Projections

Looking further ahead, several factors could influence the long-term pricing of NDC 69584-0426:

1. Technological Advancements: Improvements in manufacturing processes or the development of new drug delivery systems could impact production costs and, consequently, pricing.

2. Market Competition: The entry of new competitors or the expiration of patents for similar drugs could put downward pressure on prices.

3. Healthcare Policy Changes: Major shifts in healthcare policy, such as changes to Medicare drug pricing negotiations, could have significant impacts on pharmaceutical pricing strategies[2].

Impact of Medicare Drug Price Negotiation Program

The implementation of the Medicare Drug Price Negotiation Program is set to have a substantial impact on drug pricing in the United States. Beginning in January 2026, the first 10 negotiated prices are scheduled to take effect in Medicare Part D[2].

"Nine of the 10 drugs selected for the first year of negotiation had list price increases of 20 to 55 percent between 2018 and 2023, while the list price for one drug declined by 1 percent. Comparing Medicare's negotiated prices to list prices shows that negotiations resulted in discounts that range from a low of 38 percent to a high of 79 percent."[2]

This program could potentially influence the pricing strategy for NDC 69584-0426, especially if it falls within a therapeutic category similar to the drugs selected for negotiation.

Supply Chain Considerations

Raw Material Availability

The availability and cost of raw materials can significantly impact drug pricing. Any disruptions in the supply chain for key ingredients could lead to price fluctuations for NDC 69584-0426.

Distribution Channels

The efficiency of distribution channels plays a crucial role in determining the final price of a drug. Improvements in logistics or changes in distribution partnerships could influence the pricing strategy for NDC 69584-0426.

Competitive Landscape

Similar Drugs in the Market

Understanding the pricing and market share of drugs similar to NDC 69584-0426 can provide insights into potential price movements. Competitive pressures may influence pricing decisions, especially if there are multiple alternatives available in the market.

Patent Status

The patent status of NDC 69584-0426 and similar drugs can significantly impact pricing. As patents expire and generic versions enter the market, prices typically decrease due to increased competition[6].

Economic Factors

Inflation and Currency Fluctuations

Broader economic factors, such as inflation rates and currency exchange rates, can impact drug pricing, especially for pharmaceuticals with global supply chains or markets.

Healthcare Spending Trends

Overall trends in healthcare spending and reimbursement policies can influence pharmaceutical pricing strategies. Changes in insurance coverage or government healthcare programs may affect the pricing of drugs like NDC 69584-0426.

Technological Advancements

Manufacturing Innovations

Advancements in drug manufacturing technologies could potentially reduce production costs, which might influence pricing strategies for NDC 69584-0426 and similar drugs.

Drug Delivery Systems

Innovations in drug delivery systems could add value to existing medications, potentially justifying price adjustments. If NDC 69584-0426 benefits from such advancements, it could impact its market position and pricing.

Regulatory Landscape

Price Transparency Initiatives

Increasing focus on drug price transparency could influence pricing strategies across the pharmaceutical industry. For instance, Oregon's Drug Price Transparency Program requires manufacturers to report significant price increases[3].

International Pricing Comparisons

As discussions around international reference pricing continue, pharmaceutical companies may need to consider global pricing strategies, which could impact the U.S. pricing of drugs like NDC 69584-0426.

Patient Access and Affordability

Insurance Coverage

Changes in insurance coverage and formulary decisions can significantly impact patient access to specific drugs. The pricing strategy for NDC 69584-0426 may need to consider these factors to ensure patient accessibility.

Patient Assistance Programs

The availability and scope of patient assistance programs can influence the effective price that patients pay for medications. These programs may play a role in the overall pricing strategy for NDC 69584-0426.

Future of NDC Format

The FDA is considering changes to the NDC format due to the increasing number of drugs in the market. This potential change could have implications for drug identification and tracking systems across the healthcare industry[8].

"The FDA is running out of NDC numbers, requiring a new look at how it is structured. Nearly every system will be impacted. It is like Y2K for pharmacy!"[4]

While this change may not directly impact pricing, it could have broader implications for drug tracking and management systems, potentially influencing market dynamics.

Key Takeaways

• Drug pricing is influenced by a complex interplay of factors, including market demand, production costs, regulatory environment, and competitive landscape.
• The implementation of the Medicare Drug Price Negotiation Program could significantly impact drug pricing strategies in the coming years.
• Technological advancements, both in drug manufacturing and delivery systems, may influence future pricing trends.
• Increasing focus on price transparency and patient affordability is likely to shape pharmaceutical pricing strategies.
• The potential change in the NDC format could have far-reaching implications for drug identification and tracking systems in the healthcare industry.

FAQs

1. What is the significance of the NDC number 69584-0426? The NDC number 69584-0426 is a unique identifier for a specific drug product, providing information about its manufacturer, product type, and package size.

2. How might the Medicare Drug Price Negotiation Program affect drug pricing? The program could lead to significant discounts on selected drugs, potentially influencing pricing strategies across the pharmaceutical industry.

3. What role do patient assistance programs play in drug pricing? Patient assistance programs can influence the effective price patients pay for medications and may be considered as part of a drug's overall pricing strategy.

4. How do technological advancements impact drug pricing? Innovations in manufacturing processes and drug delivery systems can affect production costs and add value to existing medications, potentially influencing pricing.

5. Why is the FDA considering changes to the NDC format? The FDA is running out of available NDC numbers due to the increasing number of drugs in the market, necessitating a potential restructuring of the NDC format.

Sources cited: [1] https://www.fda.gov/drugs/development-approval-process-drugs/national-drug-code-database-background-information [2] https://aspe.hhs.gov/sites/default/files/documents/3e8abec86039ac0ed674a8c5fac492e3/price-change-over-time-brief.pdf [3] https://www.drugpatentwatch.com/p/drug-price/ndc/31722-0356 [4] https://www.wolterskluwer.com/en/expert-insights/are-you-prepared-for-a-major-industry-change-to-the-national-drug-code-ndc-number [8] https://www.fda.gov/media/184345/download?attachment